Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study.
OBJECTIVE
To assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls.


METHODS
Prospective cohort study.


METHODS
36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom.


METHODS
2817 schoolgirls in year 8 (12 and 13 year olds).


METHODS
Delivery of the bivalent vaccine at 0, 1, and 6 months over one school year.


METHODS
Vaccine uptake for doses 1 and 2 of a three dose schedule.


RESULTS
Vaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second dose. Uptake was significantly lower in schools with a higher proportion of ethnic minority girls (P<0.001 for trend) or higher proportion of girls entitled to free school meals (P=0.029 for trend). The main reason for parents' refusal of vaccination was insufficient information about the vaccine and its long term safety. Maintaining the vaccine schedule was challenging as 16.3% (dose 1) and 23.6% (dose 2) of girls missed their vaccination day and had to be offered alternative appointments. No serious adverse events were reported.


CONCLUSIONS
Delivery of the first two doses of HPV vaccine to adolescent schoolgirls is encouraging, but the success of the vaccination programme depends on high coverage for the third dose.
Brabin
Loretta
L
Academic Unit of Obstetrics and Gynaecology, St Mary's Hospital, University of Manchester, Manchester M13 OJH. loretta.brabin@manchester.ac.uk
Roberts
Stephen A
SA
Stretch
Rebecca
R
Baxter
David
D
Chambers
Gloria
G
Kitchener
Henry
H
McCann
Rosemary
R
D000293:Adolescent; D015331:Cohort Studies; D003695:Delivery of Health Care; D004739:England; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D011446:Prospective Studies; D012572:School Health Services; D014611:Vaccination / Q000706:statistics & numerical data
D053918:Papillomavirus Vaccines